Table 1 Comparison of clinical and biochemical characteristics of all liver diseases between BA and CC patients.
From: Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
Total | BA | CC | P | |
|---|---|---|---|---|
(N = 19) | (N = 14) | (N = 5) | ||
Male (%) | 8 (42.1) | 7 (50.0) | 1 (20.0) | |
Age (weeks) | 15.88 ± 16.80 | 19.18 ± 17.73 | 6.67 ± 10.21 | 0.033 |
AST (13.0~34.0 IU/L)* | 695.2 ± 2095.5 | 925.1 ± 2421.4 | 51.4 ± 21.9 | 0.002 |
ALT (5.0~46.0 IU/L) | 295.7 ± 620.1 | 396.0 ± 700.9 | 15.0 ± 9.4 | 0.003 |
T.Bil (0.2~0.8 mg/dL) | 8.07 ± 2.73 | 8.35 ± 1.82 | 7.28 ± 4.66 | NS |
D.Bil (0.1~0.4 mg/dL) | 4.97 ± 3.06 | 6.50 ± 1.85 | 0.70 ± 0.35 | 0.001 |
Protein (6.0~8.0 g/dL) | 5.75 ± 0.63 | 5.65 ± 0.70 | 5.60 ± 0.31 | NS |
Albumin (3.3~5.3 g/dL) | 3.68 ± 0.49 | 3.66 ± 0.54 | 3.76 ± 0.36 | NS |
γ-GT (12.0~54.0 IU/L) | 578.7 ± 779.7 | 733.4 ± 860.4 | 145.8 ± 109.0 | 0.006 |
Platelet (150.0~400 103/μL) | 354.4 ± 124.4 | 353.6 ± 133.5 | 356.8 ± 108.3 | NS |
PT-INR (0.91~1.16) | 1.07 ± 0.31 | 1.10 ± 0.35 | 0.98 ± 0.06 | 0.002 |
APRI | 13.213 ± 48.676 | 17.771 ± 56.529 | 0.454 ± 0.245 | 0.002 |
METAVIR stage, 0/1/2/3/4 | 5/0/5/8/1 | 0/0/5/8/1 | 5/0/0/0/0 |
